Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Palvella Therapeutics Inc (PVLA)

Palvella Therapeutics Inc (PVLA)
27.92 +0.31 (+1.13%) 10:12 ET [NASDAQ]
27.61 x 300 28.20 x 100
Realtime by (Cboe BZX)
27.61 x 300 28.20 x 100
Realtime - - (-) -
News & Headlines for Thu, Mar 20th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Palvella Therapeutics to Host Full Year 2024 Financial Results Conference Call on March 31, 2025

PVLA : 27.92 (+1.13%)
Palvella - Undiscovered Biotechnology Stock

Summary Palvella Therapeutics (PVLA) has shown significant price appreciation, gaining 90% since a Trend Seeker buy signal on 2/5, and 105.81% over the last year. The company focuses on developing therapies...

PVLA : 27.92 (+1.13%)
Palvella Therapeutics to Present at the TD Cowen 45th Annual Healthcare Conference

PVLA : 27.92 (+1.13%)
Palvella Therapeutics to Expand Phase 3 SELVA Clinical Trial of QTORINâ„¢ 3.9% Rapamycin Anhydrous Gel (QTORINâ„¢ rapamycin) for the Treatment of Microcystic Lymphatic Malformations to Include the Younger Pediatric Population, Children 3 to 5 Years Old

PVLA : 27.92 (+1.13%)
Palvella Therapeutics Announces Publication of Results from Phase 2 Clinical Trial of QTORINâ„¢ 3.9% Rapamycin Anhydrous Gel (QTORINâ„¢ rapamycin) for the Treatment of Microcystic Lymphatic Malformations in the Journal of Vascular Anomalies

PVLA : 27.92 (+1.13%)
Palvella Therapeutics Announces First Patients Dosed in Phase 2 TOIVA Clinical Trial of QTORINâ„¢ 3.9% Rapamycin Anhydrous Gel (QTORINâ„¢ rapamycin) for the Treatment of Cutaneous Venous Malformations

PVLA : 27.92 (+1.13%)
Stocks Pressured by Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down -0.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.20%. March E-mini S&P futures...

MSTR : 307.10 (+0.94%)
MARA : 12.92 (+3.11%)
AAPL : 216.99 (+0.81%)
HGTY : 9.18 (-0.54%)
$SPX : 5,683.71 (+0.15%)
BLDR : 130.76 (+1.93%)
$IUXX : 19,769.56 (+0.17%)
NQM25 : 20,028.00 (+0.39%)
COIN : 192.18 (+1.28%)
BRKL : 11.08 (+0.73%)
UNH : 506.90 (+0.74%)
QQQ : 483.29 (+0.50%)
Stocks Slip as Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) today is down -0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.42%. March E-mini S&P futures...

MSTR : 307.10 (+0.94%)
AAPL : 216.99 (+0.81%)
BLDR : 130.76 (+1.93%)
$IUXX : 19,769.56 (+0.17%)
COIN : 192.18 (+1.28%)
UNH : 506.90 (+0.74%)
ASML : 730.67 (-0.58%)
ZNM25 : 111-100 (+0.28%)
MHK : 116.06 (+1.35%)
ESM25 : 5,747.00 (+0.30%)
PHM : 107.30 (+2.07%)
GFS : 38.17 (-1.09%)
Palvella Therapeutics Announces Nasdaq Debut Under Ticker PVLA Following Merger with Pieris Pharmaceuticals

Palvella Therapeutics to begin trading on Nasdaq as "PVLA," focusing on rare genetic skin disease therapies with strong funding support.Quiver AI SummaryPalvella Therapeutics, a clinical-stage biopharmaceutical...

PVLA : 27.92 (+1.13%)
Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million

PVLA : 27.92 (+1.13%)

Barchart Exclusives

There Is a Buying Opportunity in July Soybean Meal Futures. Here Are the Price Levels to Watch.
Soybean traders must sense that there is not a lot of downside at present price levels in the meal futures market. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals